Webull CEO’s Most Surprising Shift Sparks B2B Push
Webull’s March-quarter results reveal a bold pivot: the CEO says B2B revenue could rival or surpass retail in the com...
When Should I Choose Cash Back Credit Card
Understand the scenarios where a cash back credit card is the best choice. Make your spending count with this guide.
26,647 articlesMemory Stocks Jump Tuesday: Micron Rally Lifts Sector
Micron Technology led a Tuesday rally in the memory sector, with peers posting solid gains as a new AMAT collaboratio...
Ives’ AI Revolution ETF Emerges as Growth-Minded Buy for 2026
A new AI-focused ETF from Wedbush-backed manager Dan Ives is drawing attention for its blend of megacap AI leaders an...
Pi Network’s Pumps After Listing Roar as BTC Stalls
PI token rockets after a major exchange adds trading, even as Bitcoin stalls below $70,000. Analysts say new liquidit...
Retirees Using Ride Taiwan’s ETF Tap Chip Boom in Tech
A growing cohort of retirees is buying into the Taiwan-centric ETF EWT to capture gains from Taiwan’s chipmakers. The...
Price Prediction: Ripple Says Big Firms Eye Crypto Payroll
Ripple asserts that CFO offices are moving crypto from pilots to production, targeting payroll and vendor payments. X...
US-Based Crypto Funds Lead Weekly Inflows in Three-Week Run
US-based crypto funds lead weekly inflows, pushing total crypto fund flows above $1 billion for a third straight week...
XRP Privacy Push Could Soon Reshape Price Trajectory
XRPL developers are testing Zero-Knowledge Proofs to hide transaction details on the XRP Ledger while preserving audi...
Meta’s Layoff Rumor Coming Sparks More Tech Cuts Ahead
A fresh round of chatter around meta’s layoff rumor coming is rattling investors, with analysts weighing how a potent...
DeFi Leaders Push More Education in U.S. Colleges Today
More than 20 DeFi projects call on U.S. universities to embed decentralized finance in core curricula, aiming to trai...
The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status